Bodyweight was recorded twice a week during the pre-treatment period, daily during the first week of the treatment and twice a week thereafter
In addition to the treatment of obesity and diabetes, unimolecular dual receptor agonists may also show an advantage in cardiovascular diseases, which could also have an impact on treatment guidelines in the near future
R.HoefgenR
Design and evaluation of four novel tripeptides as potent angiotensin converting enzyme (ACE) inhibitors with anti-hypertension activity
117, n o 3, 173179 (DOI 10.1111/bcpt.12384, lire en ligne, consult le (en) Elham Yaghubi, Maryam Daneshpazhooh, Mahmoud DJalali et Hamed Mohammadi, Effects of l carnitine supplementation on cardiovascular and bone turnover markers in patients with pemphigus vulgaris under corticosteroids treatment: A randomized, doubleblind, controlled trial , Dermatologic Therapy , vol